|
|
|
|
||
Re: Conversation with IR today, thank you AdamThe long term focus is HBV. I am sure that the use of TKM-HBV will be towards that end. Consider yourself lucky that you got in on the Oncore IPO by owning the ticker TKMR. |
return to message board, top of board |